Next generation sequencing

Combining cell-free RNA with cell-free DNA in liquid biopsy forhematologic and solid tumors
Publications

Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors

Introducing a novel liquid biopsy approach combining cfRNA and cfDNA sequencing. Our findings demonstrate superior mutation detection with cfRNA, while cfDNA excels in identifying chromosomal aberrations. Elevated cfRNA biomarkers correlate with tumor types, aiding diagnosis. Machine learning predicts cancer types accurately. Host immune response analysis through cfRNA ratios reveals distinct patterns in cancer patients. This integrated approach holds promise for predicting genomic abnormalities and cancer diagnosis

Read More »